Your Biopharma Data Needs a Strategy
In the not-so-distant past, physician prescribing data was essentially a…
Juggling Geographic Commercialization Priorities
Commercializing a pharmaceutical asset in one country is hard enough. Doing it…
Medical Affairs: An Orchestra, Not a Horse Race
Every horse race has a starting bell, a push to move as fast as possible, and a…
Three Big Mistakes
Over the past 20 years, The NemetzGroup has been involved in the launch of more…
Biopharma Launch Planning for Emerging Companies: Four Key Challenges
Living in a parallel universe, launching a company and drug simultaneously.
The Sound of Silos
We have all heard about it; some of us have lived it firsthand. A vibrant, new start-up comes to life with energy and purpose. Everyone knows one…
Nature vs. Nurture
We have been publishing these "e-conversations" for just six months now. But I am happy — no, thrilled — to see that it has already become exactly…
Where Has All the Brand Planning Strategy Gone?
Back in the Mesozoic Era, when I was coming up the marketing line (also known as the 90s), we used something called "The Mapping Approach to…
What More Can We Do To Help?
Our last newsletter concluded with the following question: "If you could have an unlimited supply of anything, what would it be?" It was a question…
Reactive Leadership in Biopharma: Breaking the Whac-A-Mole Cycle
Today we examine a pervasive challenge in our industry: time and resources wasted as middle and senior leaders respond to a seemingly endless, daily…